tirzepatide compound banned Impurity in Some Compounded 'Potentially Dangerous,' Eli Lilly Warns The FDA is proposing a

April 16, 2026: Both GLP-1 Litigations Progressing GLP-1 lawsuits based on gastroparesis and vision loss are both continuing to progress through the legal process

The danger is that these unapproved versions may contain different chemical forms (like semaglutide sodium) that havent been studied for safety or efficacy

Can Semaglutide affect kidney health

Expect visible body composition shifts at the 6 to 8 week mark

Research shows 56% of patients on GLP-1RAs had much gastric content despite following standard fasting guidelines, while only 19% of non-users showed similar results [33]

There was no head-to-head trial directly comparing these antidiabetic drug classes